Evaluation of verteporfin pharmakokinetics – redefining the need of photosensitizers in ophthalmology
Author:
Publisher
Informa UK Limited
Subject
Pharmacology,Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425255.2012.701617
Reference203 articles.
1. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
2. Verteporfin ocular photodynamic therapy
3. Improved Vision-Related Function After Ranibizumab vs Photodynamic Therapy
4. Electrooculography After Photodynamic Therapy
5. Ocular Changes after Photodynamic Therapy
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®);Ophthalmology and Therapy;2024-05-16
2. Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor‐Associated Macrophages in Prostate Cancer;Advanced Science;2023-11-29
3. Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration;Advanced Science;2023-09-14
4. Half-Fluence, Half-Dose Photodynamic Therapy: Less Direct Damage but More Inflammation?;Pharmaceuticals;2023-03-27
5. Morphological integrity of the outer retinal layers and visual prognosis in chronic central serous chorioretinopathy after half-dose photodynamic therapy: a qualitative SD-OCT analysis;Lasers in Medical Science;2022-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3